Study S001871

Umbilical Cord Mesenchymal Stem Cell Infusion With Liraglutide in Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01954147
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1; PHASE2
Masking: NONE
Status: UNKNOWN
Enrollment: 100
Start: 2013-10
Primary completion: 2014-10
Lead sponsor: Diabetes Care Center of Nanjing Military Command
Conditions: Type 2 Diabetes
Interventions: DRUG:GLP-1; BIOLOGICAL:SC; OTHER:Standard Medical Treatment
Results posted: FALSE

Registered primary outcomes

HbA1C [1 year]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0027759	[The effect of liraglutide in combination with human umbilical cord mesenchymal stem cells treatment on glucose metabolism and β cell function in type 2 diabetes mellitus]. Chen P, Zhonghua nei ke za zhi	2016	Randomized trial	PMID 27143183 DOI	cites ClinicalTrials.gov:NCT01954147; registry reference DERIVED:27143183